75岁以上老年抗栓治疗专家共识

被引：20

作者：

钱海燕

王征

何冀芳

陈冠群

卢长林

俞梦越

刘德平

机构：

[1] 海峡两岸医药卫生交流协会老年医学专业委员会

[2] 中国医学科学院阜外医院

[3] 北京大学第三医院

[4] 首都医科大学附属北京朝阳医院

[5] 台湾振兴医疗财团法人振兴医院

[6] 北京医院

来源：

中国循环杂志 | 2017年 / 32卷 / 06期

关键词：

出血风险; 抗栓治疗; 专家共识; 达比加群酯; 心房颤动; 心房纤颤; 替格瑞洛; 氯吡格雷; 阿司匹林; 乙酰水杨酸; 高龄患者; 依度沙班; 非瓣膜性; 磺达肝癸钠; 磺达肝素钠; 阿哌沙班; 出血事件; 普拉格雷; 亚洲人群; DAPT; UFH; 老年;

D O I：

暂无

中图分类号：

R54 [心脏、血管（循环系）疾病];

学科分类号：

1002 ; 100201 ;

摘要：

<正>75岁以上(≥75岁)老年人是心血管疾病的高发人群,且随着年龄增长,发病率呈显著增加趋势。约1/3罹患心肌梗死和2/3因心肌梗死死亡的患者超过75岁。制订《75岁以上老年抗栓治疗专家共识》,旨在通过总结临床研究结果并引入新的出血风险评分系统,提出适合我国75岁以上高龄患者的评价体系和抗栓建议。1高龄患者随年龄增长的病理生理变化动脉粥样硬化、血管病理和凝血因子均随年龄

引用

页码：531 / 538

页数：8

共 12 条

[1] 替格瑞洛在行经皮冠状动脉介入治疗的急性冠状动脉综合征患者中的疗效和安全性观察 [J].

李志华 ;

张亚臣 ;

解玉泉 ;

张燚 ;

徐琛华 ;

相银 ;

吴红 ;

陈漫天 ;

孟舒 ;

沈成兴 .

中国介入心脏病学杂志, 2015, 23 (08) :446-450

[2]

Age Threshold for Increased Stroke Risk Among Patients With Atrial Fibrillation[J] . Tze-Fan Chao,Kang-Ling Wang,Chia-Jen Liu,Yenn-Jiang Lin,Shih-Lin Chang,Li-Wei Lo,Yu-Feng Hu,Ta-Chuan Tuan,Fa-Po Chung,Jo-Nan Liao,Tzeng-Ji Chen,Chern-En Chiang,Gregory Y.H. Lip,Shih-Ann Chen.Journal of the American College of Cardiology . 2015 (12)

[3]

Unfractionated heparin versus bivalirudin in primary percutaneous coronary intervention (HEAT-PPCI): an open-label, single centre, randomised controlled trial[J] . Adeel Shahzad,Ian Kemp,Christine Mars,Keith Wilson,Claire Roome,Rob Cooper,Mohammed Andron,Clare Appleby,Mike Fisher,Aleem Khand,Babu Kunadian,Joseph D Mills,John L Morris,William L Morrison,Shahzad Munir,Nick D Palmer,Raphael A Perry,David R Ramsdale,Periaswamy Velavan,Rod H Stables.The Lancet . 2014 (9957)

[4] Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents [J].

Mauri, Laura ;

Kereiakes, Dean J. ;

Yeh, Robert W. ;

Driscoll-Shempp, Priscilla ;

Cutlip, Donald E. ;

Steg, P. Gabriel ;

Normand, Sharon-Lise T. ;

Braunwald, Eugene ;

Wiviott, Stephen D. ;

Cohen, David J. ;

Holmes, David R., Jr. ;

Krucoff, Mitchell W. ;

Hermiller, James ;

Dauerman, Harold L. ;

Simon, Daniel I. ;

Kandzari, David E. ;

Garratt, Kirk N. ;

Lee, David P. ;

Pow, Thomas K. ;

Lee, Peter Ver ;

Rinaldi, Michael J. ;

Massaro, Joseph M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (23) :2155-2166

[5]

Efficacy and Safety of Dabigatran Compared With Warfarin in Relation to Baseline Renal Function in Patients With Atrial Fibrillation: A RE-LY (Randomized Evaluation of Long-term Anticoagulation Therapy) Trial Analysis[J] . Ziad Hijazi,Stefan H. Hohnloser,Jonas Oldgren,Ulrika Andersson,Stuart J. Connolly,John W. Eikelboom,Michael D. Ezekowitz,Paul A. Reilly,Agneta Siegbahn,Salim Yusuf,Lars Wallentin.Circulation . 2014 (9)

[6]

Oral Antithrombotic Agents for the Prevention of Stroke in Nonvalvular Atrial Fibrillation: A Science Advisory for Healthcare Professionals From the American Heart Association/American Stroke Association[J] . Karen L. Furie,Larry B. Goldstein,Gregory W. Albers,Pooja Khatri,Ron Neyens,Mintu P. Turakhia,Tanya N. Turan,Kathryn A. Wood.Stroke . 2012 (12)

[7] THE INCIDENCE OF ARRHYTHMIAS AND CLINICAL ARRHYTHMIC EVENTS IN PATIENTS WITH ACUTE CORONARY SYNDROMES TREATED WITH TICAGRELOR OR CLOPIDOGREL IN THE PLATO TRIAL [J].

Scirica, Benjamin M. ;

Cannon, Christopher P. ;

Emanuelsson, Hakan ;

Harrington, Robert A. ;

Husted, Steen ;

James, Stefan K. ;

Katus, Hugo ;

Michelson, Eric L. ;

Prem, Pais ;

Dmitar, Raev ;

Spinar, Jindrich ;

Steg, Gabriel ;

Storey, Robert F. ;

Wallentin, Lars .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)

[8]

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial[J] . Roxana Mehran,Alexandra J Lansky,Bernhard Witzenbichler,Giulio Guagliumi,Jan Z Peruga,Bruce R Brodie,Dariusz Dudek,Ran Kornowski,Franz Hartmann,Bernard J Gersh,Stuart J Pocock,S Chiu Wong,Eugenia Nikolsky,Louise Gambone,Lynn Vandertie,Helen Parise,George D Dangas,Gregg W Stone.The Lancet . 2009 (9696)

[9]

Epidemiology, Risk Factors for Stroke, and Management of Atrial Fibrillation in China[J] . Dayi Hu,Yihong Sun.Journal of the American College of Cardiology . 2008 (10)

[10]

Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial[J] . Jonathan Mant,FD Richard Hobbs,Kate Fletcher,Andrea Roalfe,David Fitzmaurice,Gregory YH Lip,Ellen Murray.The Lancet . 2007 (9586)

← 1 2 →